Clinical Trials

Clinical trials are research studies that are designed to determine if a therapy is safe and effective for patients.

7101 Clinical Trial for Rheumatoid Arthritis

We have initiated a Phase 1 study to evaluate the safety and proof-of-mechanism of our lead Treg cell therapy candidate, SBT-77-7101, in patients with rheumatoid arthritis.

For more information, please visit our clinical trial website.

Learn More

5301 Clinical Trial

We are conducting a Phase 1 study of SBT-11-5301, our effector T cell-modulating biologic, in healthy participants.

For more information, please see the 5301 study on ClinicalTrials.gov.

Learn More